33 related articles for article (PubMed ID: 18154769)
1. Neoadjuvant therapy for gastric cancer: current evidence and future directions.
Newton AD; Datta J; Loaiza-Bonilla A; Karakousis GC; Roses RE
J Gastrointest Oncol; 2015 Oct; 6(5):534-43. PubMed ID: 26487948
[TBL] [Abstract][Full Text] [Related]
2. Sphincter preservation in distal CT2N0 rectal cancer after preoperative chemoradiotherapy.
Wasserberg N; Kundel Y; Purim O; Keidar A; Kashtan H; Sadot E; Fenig E; Brenner B
Radiat Oncol; 2014 Oct; 9():233. PubMed ID: 25338839
[TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with sphincter-preserving resection in patients with low rectal cancer.
Cong ZJ; Hu LH; Xing JJ; Zhang W; Fu CG; Yu ED; Zhong M
Int Surg; 2014; 99(4):330-7. PubMed ID: 25058761
[TBL] [Abstract][Full Text] [Related]
4. Preoperative concurrent chemoradiotherapy for locally advanced rectal cancer: treatment outcomes and analysis of prognostic factors.
Kong M; Hong SE; Choi WS; Kim SY; Choi J
Cancer Res Treat; 2012 Jun; 44(2):104-12. PubMed ID: 22802748
[TBL] [Abstract][Full Text] [Related]
5. Effect of multidisciplinary team treatment on outcomes of patients with gastrointestinal malignancy.
Du CZ; Li J; Cai Y; Sun YS; Xue WC; Gu J
World J Gastroenterol; 2011 Apr; 17(15):2013-8. PubMed ID: 21528081
[TBL] [Abstract][Full Text] [Related]
6. Options for sphincter preservation in surgery for low rectal cancer.
Tytherleigh MG; McC Mortensen NJ
Br J Surg; 2003 Aug; 90(8):922-33. PubMed ID: 12905543
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations.
Habr-Gama A; Perez RO; Kiss DR; Rawet V; Scanavini A; Santinho PM; Nadalin W
Hepatogastroenterology; 2004; 51(60):1703-7. PubMed ID: 15532809
[TBL] [Abstract][Full Text] [Related]
8. Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer.
Ueno H; Mochizuki H; Hashiguchi Y; Ishikawa K; Fujimoto H; Shinto E; Hase K
Ann Surg; 2004 Jan; 239(1):34-42. PubMed ID: 14685098
[TBL] [Abstract][Full Text] [Related]
9. [Effects of neoadjuvant chemoradiotherapy on the rates of sphincter preserving surgery in lower rectal cancer and analysis of their prognostic factors].
Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):419-423. PubMed ID: 27938574
[No Abstract] [Full Text] [Related]
10. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and preoperative radiation therapy associated with sphincter preservation in patients with resectable rectal cancer.
Howard JH; Gonzalez Q; Arnoletti JP; Russo S; Fiveash JB; Bland KI; Heslin MJ
Am J Surg; 2008 Feb; 195(2):239-43. PubMed ID: 18154769
[TBL] [Abstract][Full Text] [Related]
12. Sphincter preservation therapy for rectal cancer.
Aitken C; Breen E; Mamon HJ
Clin Adv Hematol Oncol; 2003 Dec; 1(12):735-40. PubMed ID: 16258478
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
